In this podcast, Brom interviews the CSO of Xylo, Sam Banister. Sam explains how new chemical entities are reshaping the psychedelic field; how novel psychedelic molecules are made, and how new chemical entities are going to play a dominant role in the future of psychedelic medicine.
Stay up to date on Human 3 - the new epoch of health, wellbeing and performance